Oxytocin
- PMID: 29939625
- Bookshelf ID: NBK507848
Oxytocin
Excerpt
Oxytocin is FDA-approved for use in the antepartum and postpartum periods to facilitate labor and control postpartum hemorrhage. Antepartum indications include preeclampsia, maternal diabetes, premature rupture of membranes, uterine inactivity requiring labor stimulation, and second-trimester inevitable or incomplete abortions. Postpartum use focuses on promoting uterine contractions to reduce hemorrhage risk. A detailed review of oxytocin's mechanism of action, dosing, contraindications, and adverse effect profile provides critical insights for optimizing clinical use.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- ACOG Practice Bulletin No. 135: Second-trimester abortion. Obstet Gynecol. 2013 Jun;121(6):1394-1406. - PubMed
-
- Gonzalez SC, Budge J, Butler PD, Higgs M, Whiting J, Lutgendorf MA. An evidence-based oxytocin protocol for the third stage of labor to improve hemorrhage outcomes. Int J Qual Health Care. 2021 Feb 20;33(1) - PubMed
-
- Yin H, Jiang M, Han T, Xu X. Intranasal oxytocin as a treatment for anxiety and autism: From subclinical to clinical applications. Peptides. 2024 Jun;176:171211. - PubMed
-
- Sentilhes L, Madar H, Ducarme G, Hamel JF, Mattuizzi A, Hanf M. Outcomes of operative vaginal delivery managed by residents under supervision and attending obstetricians: a prospective cross-sectional study. Am J Obstet Gynecol. 2019 Jul;221(1):59.e1-59.e15. - PubMed
-
- Saccone G, Della Corte L, Maruotti GM, Quist-Nelson J, Raffone A, De Vivo V, Esposito G, Zullo F, Berghella V. Induction of labor at full-term in pregnant women with uncomplicated singleton pregnancy: A systematic review and meta-analysis of randomized trials. Acta Obstet Gynecol Scand. 2019 Aug;98(8):958-966. - PubMed
Publication types
LinkOut - more resources
Full Text Sources